EODData

MEMBERSHIP REGISTER LOG IN

FRA, PA8: Paion AG

27 Mar 2026
LAST:

0.0324

CHANGE:
 0.00		OPEN:
0.0324		HIGH:
0.0324		ASK:
0.0000		VOLUME:
113
CHG(%):
0.61		PREV:
0.0326		LOW:
0.0324		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Mar 260.03240.03240.03240.0324113
26 Mar 260.04240.04240.03260.032610
25 Mar 260.08460.08460.04260.0426106
24 Mar 260.08980.08980.08980.089820
23 Mar 260.08000.08000.08000.080055
20 Mar 260.04260.04260.04260.0426270
19 Mar 260.04200.09980.04200.0996325
18 Mar 260.06500.07200.06500.07203.9K
17 Mar 260.06500.07020.06500.07021.0K
16 Mar 260.06500.06500.06500.06500

PROFILE

Name:Paion AG
About:Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.
Address:Heussstrasse 25, Aachen, Germany, 52078
Website:https://www.paion.com
ISIN:DE000A0B65S3
LEI:529900CGHB9UWY40BU45

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.15 
Forward P/E:72.46 
PEG Ratio:0.00 
Price to Sales:0.00 
Price to Book:-0.03 
Profit Margin:0.94 
Operating Margin:0.08 
Return on Assets:-0.02 
Return on Equity:-0.09 
Revenue:33.25M 
EBITDA:4.31M 
Shares:7.13M 
Market Cap:231.1K 

TECHNICAL INDICATORS

MA5:0.0671.3%
MA10:0.0693.5%
MA20:0.07108.3%
MA50:0.08139.5%
MA100:0.0540.7%
MA200:0.0314.1%
RSI14:41.50
WPR14:-100.00 
MTM14:-0.03
ROC14:-0.51 
ATR:0.02 
Week High:0.09177.2%
Week Low:0.030.0%
Month High:0.12268.8%
Month Low:0.0314.1%
Year High:0.23609.9%
Year Low:0.01362.9%

RECENT SPLITS

Date Ratio
12 Apr 20231-10